Marc‐André Bellavance

698 total citations
9 papers, 534 citations indexed

About

Marc‐André Bellavance is a scholar working on Neurology, Immunology and Oncology. According to data from OpenAlex, Marc‐André Bellavance has authored 9 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 5 papers in Immunology and 2 papers in Oncology. Recurrent topics in Marc‐André Bellavance's work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Immune cells in cancer (4 papers) and Immune Response and Inflammation (3 papers). Marc‐André Bellavance is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Immune cells in cancer (4 papers) and Immune Response and Inflammation (3 papers). Marc‐André Bellavance collaborates with scholars based in Canada and United States. Marc‐André Bellavance's co-authors include Serge Rivest, David Fortin, Jean-Philippe Michaud, Paul Préfontaine, Marie Blanchette, David Gosselin, Peter K. Stys, V. Wee Yong and Sébastien Drolet and has published in prestigious journals such as Immunological Reviews, International Journal of Pharmaceutics and Cell Reports.

In The Last Decade

Marc‐André Bellavance

9 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc‐André Bellavance Canada 8 259 135 126 123 72 9 534
Matteo Tamborini Italy 7 227 0.9× 169 1.3× 105 0.8× 260 2.1× 94 1.3× 8 616
Dario Carradori Belgium 10 203 0.8× 107 0.8× 107 0.8× 189 1.5× 84 1.2× 12 604
Carmen Mecca Italy 12 320 1.2× 158 1.2× 104 0.8× 249 2.0× 46 0.6× 14 691
Robert S. Pulido United States 3 302 1.2× 34 0.3× 91 0.7× 196 1.6× 106 1.5× 3 620
Pooja Joshi Italy 11 339 1.3× 150 1.1× 135 1.1× 431 3.5× 44 0.6× 16 776
Divya Channappa United States 7 191 0.7× 88 0.7× 81 0.6× 112 0.9× 43 0.6× 10 373
Jens O. Watzlawik United States 16 147 0.6× 90 0.7× 170 1.3× 322 2.6× 150 2.1× 36 837
Waël Alata Canada 11 281 1.1× 45 0.3× 309 2.5× 325 2.6× 183 2.5× 15 885
Blerta Milo United States 6 165 0.6× 39 0.3× 141 1.1× 172 1.4× 72 1.0× 6 691
Yue He China 11 174 0.7× 66 0.5× 43 0.3× 245 2.0× 65 0.9× 26 579

Countries citing papers authored by Marc‐André Bellavance

Since Specialization
Citations

This map shows the geographic impact of Marc‐André Bellavance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc‐André Bellavance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc‐André Bellavance more than expected).

Fields of papers citing papers by Marc‐André Bellavance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc‐André Bellavance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc‐André Bellavance. The network helps show where Marc‐André Bellavance may publish in the future.

Co-authorship network of co-authors of Marc‐André Bellavance

This figure shows the co-authorship network connecting the top 25 collaborators of Marc‐André Bellavance. A scholar is included among the top collaborators of Marc‐André Bellavance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc‐André Bellavance. Marc‐André Bellavance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Bellavance, Marc‐André, et al.. (2015). Role of adaptor protein MyD88 in TLR-mediated preconditioning and neuroprotection after acute excitotoxicity. Brain Behavior and Immunity. 46. 221–231. 34 indexed citations
3.
Bellavance, Marc‐André, et al.. (2015). Bone marrow-derived macrophages and the CNS: An update on the use of experimental chimeric mouse models and bone marrow transplantation in neurological disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(3). 310–322. 41 indexed citations
4.
Bellavance, Marc‐André, David Gosselin, V. Wee Yong, Peter K. Stys, & Serge Rivest. (2014). Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity. Brain Structure and Function. 220(3). 1759–1776. 32 indexed citations
5.
Gosselin, David, Marc‐André Bellavance, & Serge Rivest. (2013). IL-1RAcPb signaling regulates adaptive mechanisms in neurons that promote their long-term survival following excitotoxic insults. Frontiers in Cellular Neuroscience. 7. 9–9. 15 indexed citations
6.
Michaud, Jean-Philippe, Marc‐André Bellavance, Paul Préfontaine, & Serge Rivest. (2013). Real-Time In Vivo Imaging Reveals the Ability of Monocytes to Clear Vascular Amyloid Beta. Cell Reports. 5(3). 646–653. 192 indexed citations
7.
Bellavance, Marc‐André & Serge Rivest. (2012). The neuroendocrine control of the innate immune system in health and brain diseases. Immunological Reviews. 248(1). 36–55. 45 indexed citations
8.
Bellavance, Marc‐André, et al.. (2010). Uptake and intracellular release kinetics of liposome formulations in glioma cells. International Journal of Pharmaceutics. 395(1-2). 251–259. 39 indexed citations
9.
Bellavance, Marc‐André, Marie Blanchette, & David Fortin. (2008). Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy. The AAPS Journal. 10(1). 166–177. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026